Glicada para el diagnóstico de la diabetes, ¿un estándar universal?

Abstract

In August 2009, an ad hoc international expert committee created by the major world diabetic association, published an eagerly awaited consensus. In this, it recommended the general use of the haemoglobin A1c fraction for the diagnosis of diabetes, encouraging its standardisation and proposing a 6.5% cut-off. In this article, the diagnostic methods for diabetes, as well as the advantages, limitations and controversies of this new recommendation are reviewed.

Hemoglobin AIc: A reliable and accurate test for diabetes care? A prospective study in Mexico

“…23 Our results and other recent publications in different countries have recognized severe problems in this regard and their comments are in opposition to the statement of a completed globalization in HbA1c measurement. [24][25][26] Again, our evaluation, based on an experimental model of daily clinical practice, in an adequate sample size, has shown a critical issue concerning diabetes management by different statistical methods; a very poor concordance or agreement in HbA1c results was found in more than half of the participating laboratories. The robust clinical significance of our results would not change with involvement of more clinical laboratories or subjects.…”